6489.5000 128.00 (2.01%)
NSE Aug 04, 2025 15:31 PM
Volume: 351.2K
 

6489.50
2.01%
Phillip Capital
Outlook and valuation: While earnings were higher than we expected, H1 performance is almost in line with our FY16 expectations. Hence, we have maintained our estimates for FY16/17 and continue to value the company at Rs 1045 (22x FY17 earnings), implying 9%...
Divi's Laboratories Ltd. is trading below its 30 day SMA of 6727.9
More from Divi's Laboratories Ltd.
Recommended